Literature DB >> 11919261

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.

Christine Franzius, Andreas Schuck, Stefan S Bielack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11919261     DOI： 10.1200/JCO.2002.20.7.1953

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma.

Authors:  Angela Dispenzieri; Gregory A Wiseman; Martha Q Lacy; Suzanne R Hayman; Shaji K Kumar; Francis Buadi; David Dingli; Krista M Laumann; Jake Allred; Susan M Geyer; Mark R Litzow; Dennis A Gastineau; David J Inwards; Ivana N Micallef; Stephen M Ansell; Luis Porrata; Michelle A Elliott; Patrick B Johnston; William J Hogan; Morie A Gertz
Journal:  Am J Hematol       Date:  2010-06       Impact factor: 10.047

Review 2.  Radiopharmaceuticals for Treatment of Osteosarcoma.

Authors:  Peter M Anderson
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 3.  Management of osteosarcoma.

Authors:  Jeremy Whelan; Beatrice Seddon; Martha Perisoglou
Journal:  Curr Treat Options Oncol       Date:  2006-11

4.  Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma.

Authors:  K Lia; Ø S Bruland; H L Randem; L H Aksnes; J P Poulsen; I Taksdal; K Sundby Hall
Journal:  J Bone Oncol       Date:  2013-10-11       Impact factor: 4.072
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.